Dr. Jennifer McVean, MD, is a nationally recognized pediatric endocrinologist and diabetes specialist dedicated to improving the lives of children and families affected by diabetes and endocrine disorders. Diagnosed with Type 1 diabetes at age 11, Dr. McVean brings a unique perspective to patient care, combining her personal experience with extensive medical expertise.
After earning her medical degree from the University of Minnesota Medical School, Dr. McVean completed her pediatric residency at the University of Colorado and a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in Pediatrics and Pediatric Endocrinology.
Throughout her career, Dr. McVean has held leadership, academic, and clinical positions with respected healthcare organizations, including the University of Minnesota, Children’s Minnesota, Gundersen Health System, Hudson Physicians, and Medtronic Diabetes. Her work has contributed to advancements in automated insulin delivery systems, diabetes technology adoption, and improved outcomes for pediatric patients worldwide.
In her current role as Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean focuses on developing and implementing innovative diabetes technologies. She has been actively involved in research studies evaluating the effectiveness of automated insulin delivery systems, such as the MiniMed™ 780G system, in improving glycemic control and reducing the burden of diabetes management for children and their families.
Dr. McVean’s commitment extends beyond clinical practice and research. She has been actively involved with numerous diabetes advocacy and educational organizations, including the Juvenile Diabetes Research Foundation (JDRF), the American Diabetes Association (ADA), ADA Camp Needlepoint, the TrialNet Research Network, and the Pediatric Endocrine Society. Through these affiliations, she has dedicated years to mentoring, research, education, and community outreach focused on improving diabetes awareness, prevention, and treatment.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
To learn more about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.